Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Common Equity (2016 - 2025)

Historic Common Equity for InspireMD (NSPR) over the last 16 years, with Q3 2025 value amounting to $64.1 million.

  • InspireMD's Common Equity rose 5504.82% to $64.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.1 million, marking a year-over-year increase of 5504.82%. This contributed to the annual value of $36.1 million for FY2024, which is 864.54% down from last year.
  • As of Q3 2025, InspireMD's Common Equity stood at $64.1 million, which was up 5504.82% from $20.2 million recorded in Q2 2025.
  • InspireMD's Common Equity's 5-year high stood at $64.1 million during Q3 2025, with a 5-year trough of $13.4 million in Q1 2023.
  • Its 5-year average for Common Equity is $35.0 million, with a median of $36.1 million in 2024.
  • In the last 5 years, InspireMD's Common Equity soared by 116413.57% in 2021 and then plummeted by 5671.15% in 2025.
  • Over the past 5 years, InspireMD's Common Equity (Quarter) stood at $33.5 million in 2021, then plummeted by 48.13% to $17.4 million in 2022, then surged by 127.11% to $39.5 million in 2023, then fell by 8.65% to $36.1 million in 2024, then soared by 77.67% to $64.1 million in 2025.
  • Its last three reported values are $64.1 million in Q3 2025, $20.2 million for Q2 2025, and $28.3 million during Q1 2025.